Nuvo Pharmaceuticals Inc
TSX:MRV
Income Statement
Earnings Waterfall
Nuvo Pharmaceuticals Inc
Revenue
|
72.4m
CAD
|
Cost of Revenue
|
-27.4m
CAD
|
Gross Profit
|
45.1m
CAD
|
Operating Expenses
|
-32.6m
CAD
|
Operating Income
|
12.4m
CAD
|
Other Expenses
|
2.8m
CAD
|
Net Income
|
15.2m
CAD
|
Income Statement
Nuvo Pharmaceuticals Inc
Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
26
N/A
|
25
-6%
|
21
-16%
|
13
-39%
|
18
+45%
|
18
+1%
|
19
+3%
|
19
+3%
|
13
-32%
|
13
-2%
|
15
+12%
|
14
-6%
|
16
+18%
|
21
+26%
|
24
+17%
|
29
+21%
|
29
+0%
|
27
-7%
|
26
-3%
|
21
-19%
|
19
-12%
|
18
-6%
|
15
-14%
|
18
+19%
|
20
+12%
|
20
+1%
|
30
+51%
|
41
+36%
|
55
+34%
|
70
+27%
|
79
+14%
|
78
-1%
|
76
-3%
|
74
-3%
|
64
-13%
|
68
+7%
|
68
+1%
|
69
+1%
|
70
+2%
|
71
+2%
|
72
+2%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(8)
|
(7)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(7)
|
(8)
|
(10)
|
(10)
|
(12)
|
(12)
|
(11)
|
(11)
|
(9)
|
(8)
|
(8)
|
(7)
|
(8)
|
(9)
|
(9)
|
(12)
|
(17)
|
(22)
|
(26)
|
(26)
|
(25)
|
(24)
|
(23)
|
(23)
|
(23)
|
(22)
|
(24)
|
(26)
|
(26)
|
(27)
|
|
Gross Profit |
19
N/A
|
17
-7%
|
14
-17%
|
7
-51%
|
13
+83%
|
14
+6%
|
14
+2%
|
14
+4%
|
8
-43%
|
8
-9%
|
8
+5%
|
7
-15%
|
8
+18%
|
11
+36%
|
14
+26%
|
17
+28%
|
17
0%
|
16
-9%
|
15
-3%
|
12
-22%
|
10
-14%
|
9
-8%
|
8
-18%
|
10
+25%
|
11
+16%
|
11
+2%
|
18
+57%
|
24
+34%
|
32
+35%
|
43
+33%
|
53
+23%
|
53
+1%
|
52
-2%
|
50
-3%
|
41
-18%
|
45
+8%
|
46
+4%
|
44
-4%
|
44
0%
|
46
+3%
|
45
-1%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(22)
|
(21)
|
(19)
|
(17)
|
(17)
|
(17)
|
(23)
|
(24)
|
(18)
|
(21)
|
34
|
36
|
(12)
|
(4)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(13)
|
(18)
|
(25)
|
(33)
|
(36)
|
(36)
|
(34)
|
(31)
|
(30)
|
(30)
|
(30)
|
(30)
|
(31)
|
(31)
|
(50)
|
(32)
|
(33)
|
|
Selling, General & Administrative |
(15)
|
(14)
|
(12)
|
(10)
|
(9)
|
(9)
|
(9)
|
(10)
|
(11)
|
(13)
|
(10)
|
(9)
|
(7)
|
(3)
|
(5)
|
(6)
|
(6)
|
(7)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(8)
|
(11)
|
(16)
|
(22)
|
(28)
|
(29)
|
(27)
|
(26)
|
(23)
|
(22)
|
(21)
|
(22)
|
(23)
|
(23)
|
(24)
|
(25)
|
(25)
|
(26)
|
|
Research & Development |
(7)
|
(7)
|
(7)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(6)
|
(5)
|
(4)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(5)
|
(7)
|
(9)
|
(8)
|
(8)
|
(8)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(6)
|
0
|
0
|
51
|
51
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(18)
|
0
|
0
|
|
Operating Income |
(4)
N/A
|
(3)
+6%
|
(5)
-29%
|
(10)
-129%
|
(4)
+64%
|
(4)
+7%
|
(10)
-172%
|
(9)
+2%
|
(10)
-9%
|
(14)
-33%
|
41
N/A
|
43
+3%
|
(4)
N/A
|
7
N/A
|
8
+12%
|
11
+41%
|
10
-4%
|
8
-26%
|
7
-2%
|
5
-36%
|
3
-27%
|
2
-51%
|
(1)
N/A
|
0
N/A
|
(2)
N/A
|
(7)
-338%
|
(8)
-10%
|
(9)
-25%
|
(4)
+62%
|
7
N/A
|
19
+165%
|
22
+16%
|
22
+1%
|
20
-8%
|
12
-43%
|
14
+23%
|
15
+7%
|
13
-15%
|
(6)
N/A
|
13
N/A
|
12
-6%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
(6)
|
25
|
26
|
23
|
19
|
(17)
|
(24)
|
(22)
|
(32)
|
(23)
|
(23)
|
(26)
|
(4)
|
6
|
11
|
|
Non-Reccuring Items |
1
|
(9)
|
(7)
|
(8)
|
(16)
|
(6)
|
0
|
0
|
52
|
51
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(24)
|
(24)
|
(24)
|
(24)
|
(0)
|
(0)
|
(2)
|
(1)
|
(1)
|
(16)
|
(18)
|
0
|
(19)
|
(4)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
1
|
1
|
1
|
1
|
(3)
|
(4)
|
(3)
|
(3)
|
0
|
2
|
2
|
1
|
1
|
0
|
(0)
|
(0)
|
|
Pre-Tax Income |
(4)
N/A
|
(13)
-270%
|
(13)
+5%
|
(19)
-49%
|
(20)
-5%
|
(10)
+49%
|
(10)
+5%
|
(10)
-1%
|
43
N/A
|
39
-10%
|
43
+12%
|
45
+4%
|
(2)
N/A
|
8
N/A
|
8
-1%
|
11
+36%
|
10
-8%
|
7
-29%
|
8
+4%
|
5
-35%
|
4
-30%
|
2
-55%
|
(1)
N/A
|
0
N/A
|
(2)
N/A
|
(6)
-246%
|
(13)
-111%
|
(8)
+43%
|
(1)
+88%
|
3
N/A
|
10
+204%
|
2
-83%
|
(5)
N/A
|
(3)
+44%
|
(20)
-584%
|
(8)
+60%
|
(22)
-173%
|
(29)
-32%
|
(9)
+69%
|
0
N/A
|
19
+3 950%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
|
Income from Continuing Operations |
(4)
|
(14)
|
(13)
|
(19)
|
(20)
|
(10)
|
(10)
|
(10)
|
43
|
39
|
43
|
45
|
(3)
|
8
|
8
|
11
|
10
|
7
|
8
|
5
|
4
|
2
|
(1)
|
0
|
(2)
|
(6)
|
(13)
|
(8)
|
(1)
|
3
|
9
|
0
|
(7)
|
(4)
|
(20)
|
(9)
|
(24)
|
(32)
|
(12)
|
(3)
|
15
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(4)
N/A
|
(14)
-279%
|
(13)
+5%
|
(19)
-48%
|
(20)
-5%
|
(10)
+48%
|
(10)
+5%
|
(10)
-1%
|
43
N/A
|
39
-10%
|
41
+6%
|
37
-9%
|
(14)
N/A
|
(7)
+47%
|
(8)
-14%
|
0
N/A
|
3
+697%
|
4
+52%
|
8
+82%
|
5
-35%
|
4
-30%
|
2
-55%
|
(1)
N/A
|
0
N/A
|
(2)
N/A
|
(6)
-258%
|
(13)
-118%
|
(8)
+43%
|
(1)
+90%
|
3
N/A
|
9
+167%
|
0
-97%
|
(7)
N/A
|
(4)
+41%
|
(20)
-394%
|
(9)
+55%
|
(24)
-161%
|
(32)
-33%
|
(12)
+62%
|
(3)
+75%
|
15
N/A
|
|
EPS (Diluted) |
-0.41
N/A
|
-1.55
-278%
|
-1.46
+6%
|
-2.17
-49%
|
-2.28
-5%
|
-1.18
+48%
|
-1.12
+5%
|
-0.97
+13%
|
4.12
N/A
|
3.76
-9%
|
3.78
+1%
|
3.43
-9%
|
-1.23
N/A
|
-0.65
+47%
|
-0.71
-9%
|
0.02
N/A
|
0.23
+1 050%
|
0.36
+57%
|
0.65
+81%
|
0.42
-35%
|
0.3
-29%
|
0.13
-57%
|
-0.07
N/A
|
0.04
N/A
|
-0.15
N/A
|
-0.54
-260%
|
-1.18
-119%
|
-0.67
+43%
|
-0.07
+90%
|
0.3
N/A
|
0.8
+167%
|
0.03
-96%
|
-0.61
N/A
|
-0.36
+41%
|
-1.79
-397%
|
-0.29
+84%
|
-2.12
-631%
|
-2.83
-33%
|
-0.36
+87%
|
-0.09
+75%
|
0.49
N/A
|